Dr. Rajiv Ramesh Rathod, MD

Dr. Rathod practices at Elite Surgery Center of Orange County Inc in Santa Ana, California.

Dr. Rathod's NPI, 1821201351, was assigned on May 8, 2007. Dr. Rathod graduated from Vanderbilt University School Of Medicine in 2005. Dr. Rathod holds California license A120894.

Dr. Rathod's primary practice is Elite Surgery Center of Orange County Inc, at 999 N Tustin Ave, Santa Ana, CA 92705 in Orange County. The practice phone is (949) 566-8688.

Dr. Rathod's primary practice is Elite Surgery Center of Orange County Inc in Santa Ana, California. Dmand AI also links Dr. Rathod to 1 group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Rathod practices. Vendor and product names are available with a free account.

Ophthalmology is Dr. Rathod's primary specialty in the NPI Registry, under taxonomy code 207W00000X. Dr. Rathod is board certified in ophthalmology by the American Board of Ophthalmology. Dmand AI has Dr. Rathod's licenses on file in 3 states: California, Illinois and Missouri.

Dmand AI lists age-related macular degeneration, cataract, cataract surgery with lens implant, conjunctivitis, dry eye, eye infection or inflammation, eyelid inflammation and glaucoma among the conditions Dr. Rathod treats.

CMS data shows 65,593 Medicare services from Dr. Rathod across 20 procedure codes in 2024, for 1,292 Medicare patients. Medicare paid $4,563,727 for them.

CMS counts 1,292 Medicare patients who saw Dr. Rathod in 2024. The largest group is 65 to 74, with 507 patients. 75% of them have high cholesterol, and 73% have high blood pressure. 10% are also on Medicaid. Their average risk score is 1.39, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Rathod's median patient age at 72, with 56% women.

In 2024, Dr. Rathod wrote 1,305 Medicare Part D claims for 358 patients. 55% of them were for generic drugs. CMS names the drug for 1,215 of them, across 24 drugs with 11 or more claims each, at $134,250 in total drug cost. In 2023, CMS named 1,054 claims across 23 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Rathod for performance year 2024, reported as part of a group. Dr. Rathod accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Cataract surgery: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 5 papers to Dr. Rathod, published from 2013 to 2020. 2020 was the busiest year, with 2. The most frequent topics are Retinal Detachment. Dr. Rathod's most frequent co-authors are Sanford Chen, MD, John M. Maggiano, MD and Timothy T. You, MD.

CMS Open Payments shows 478 general payments to Dr. Rathod from 36 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 36% of the total. Regeneron Pharmaceuticals, Inc. paid the most, $38,142. It also lists 6 research payments totaling $23,561 from 2017 to 2024.

Dr. Rathod graduated from Vanderbilt University School Of Medicine in 2005.

Dr. Rathod is in network with 14 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. Medicare plans come from the most carriers, 8. Check the plan with the practice before a visit.